Financials

	2024	2025
Net sales	492K 421K 394K 361K 679K 47.07M 687K 4.65M 1.81M 23.64M 1.85M 1.81M 78.16M	89K 76.22K 71.23K 65.28K 123K 8.52M 124K 841K 328K 4.28M 334K 327K 14.14M
Net income	-1.04M -891K -832K -763K -1.44M -99.51M -1.45M -9.83M -3.83M -49.96M -3.9M -3.82M -165M	-3.98M -3.41M -3.18M -2.92M -5.49M -380M -5.55M -37.58M -14.66M -191M -14.93M -14.6M -632M
Net Debt	6.22M 5.32M 4.98M 4.56M 8.58M 595M 8.68M 58.76M 22.92M 299M 23.34M 22.83M 988M	911K 780K 729K 668K 1.26M 87.16M 1.27M 8.61M 3.36M 43.77M 3.42M 3.35M 145M

* Estimated data More financial data

Company Profile

DXI Capital Corp. is a Canada-based company. The Company has no active operations. It does not generate revenue from its operations. The Companyâ€™s wholly owned subsidiary is 0855524 B.C. Ltd.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-08-21	$0.2200	+10.00%	3,771
26-08-20	$0.2000	-20.00%	5,500
26-08-19	$0.2500	+4.17%	500

Delayed Quote Toronto S.E.

More quotes

Market Closed - Toronto S.E. 15:37:11 2026-08-21 EDT			5-day change	1st Jan Change
0.2200 ^CAD	+10.00%		-8.33%	-26.67%

06-30	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	11.6M 9.93M 9.28M 8.51M 16.01M 1.11B 16.19M 110M 42.76M 557M 43.55M 42.6M 1.84B	P/E 2024 *	-	P/E 2025	-2.71x
Enterprise Value	12.51M 10.71M 10.01M 9.18M 17.27M 1.2B 17.46M 118M 46.12M 601M 46.97M 45.95M 1.99B	EV / Sales 2024 *	-	EV / Sales 2025	175x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

06-30	VVT Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-30	VVT Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
06-29	VVT Med Inc. Auditor Raises 'Going Concern' Doubt	CI
06-26	VVT Med Signs Exclusive Distribution Deal in Greece Worth About C$1.14 Million	MT
06-26	VVT Med Inc. Enters Exclusive Distribution Agreement With General Chemical Products S.A. For ScleroSafe Platform In Greece	CI
06-11	VVT Med Enters Dominican Republic Market	MT
06-11	VVT Med Inc. Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	CI
05-26	VVT Med Announces First Patients Treated with VVT?s ScleroSafe System in Italy	CI
04-30	VVT Med Inc Announces Positive Clinical Data For ScleroSafe Catheter-Directed Sclerotherapy System	CI
04-27	VVT Med Signs "Largest" European Distribution Agreement to Date	MT
04-27	VVT Med Inc. Signs Exclusive Distribution Agreement With Uber Ros S.p.A. For ScleroSafe System In Italy, Vatican City And Republic Of San Marino	CI
04-22	VVT Med Closes First Tranche In Private Placement of Units	MT
03-17	VVT Med Inc. announced that it expects to receive $3.000001 million in funding	CI

08-21	VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure	AQ
06-26	VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece	AQ
06-12	VVT Med Provides Update on Management Cease Trade Order	AQ
06-11	VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor	GL
05-29	VVT Med Provides Update on Management Cease Trade Order	AQ

VVT Med Inc. Stock

Stocks

VVTM

CA91841T1084

Medical Equipment, Supplies & Distribution

Valuation: VVT Med Inc.

Chart: VVT Med Inc.

Latest news : VVT Med Inc.

Press Releases: VVT Med Inc.

News in other languages: VVT Med Inc.

Quotes and Performance

Course Extremes

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

11-26	VVT Medical Inc. (VVTM) ouvre les marchés
23-11-23	Sopra Steria Group: Willy il Coyote cerca di tenere il passo con Bip Bip
23-11-23	Sopra Steria Group: Coyote intenta seguir el ritmo de Bip Bip
23-11-23	Sopra Steria Group : le Coyote tente de suivre Bip Bip

1 day	+10.00%
1 week	-8.33%
1 month	+4.76%
3 months	+15.79%
6 months	-24.14%
Current year	-26.67%

1 week	0.2	0.27
1 month	0.2	0.28
Current year	0.17	0.45
1 year	0.15	0.49
3 years	0.15	0.56
5 years	0.15	0.56
10 years	0.15	0.56

Date	Insider	Type	Main position	Quantity	% Market Cap.
4/28/26	Erez Tetro	Other	Chief Executive Officer	0	0%
4/23/26	Erez Tetro	Other	Chief Executive Officer	0	0%
10/5/20	Ronnie Bozzer	Option		6,000	0.0024%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VVT MED INC.	+10.00%	-8.33%	-51.11%	-	11.6M
ABBOTT LABORATORIES	+2.19%	+4.84%	-12.03%	+10.93%	202B
MEDTRONIC PLC	+1.14%	+2.28%	+0.69%	+11.50%	119B
CENCORA, INC.	+1.06%	+1.34%	+8.69%	+78.71%	60.69B
HOYA CORPORATION	-1.37%	-6.57%	+30.31%	+55.01%	52.38B
BECTON, DICKINSON AND COMPANY	+2.33%	+4.69%	-3.84%	-30.36%	52.3B
DEXCOM, INC.	+2.35%	+2.89%	+12.25%	-13.68%	34.85B
MEDLINE INC.	+5.16%	-4.14%	-	-	30.06B
WEST PHARMACEUTICAL SERVICES, INC.	-0.20%	+1.05%	+42.46%	-10.20%	24.85B
TERUMO CORPORATION	-0.29%	-3.87%	-6.19%	+25.59%	23.84B
Average	+2.24%	-0.58%	+2.36%	+15.94%	60.03B
Weighted average by Cap.	+1.53%	+1.90%	+1.58%	+16.71%